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ABSTRACT : To determine the characteristics of the elderly in high - resolution com- 
puted tomography (HRcT) lung densitometry, mean lung density (MLD) and relative 
area of the lungs showing attenuation values less than -950 HU (RAW) on HRCT were 
evaluated in nonsmoking control subjects (n = 80) and patients with asthma (n = 80) 
in relation to their age and pulmonary function. MLD was significantly decreased, and 
RAW was significantly increased with increasing age in both asthmatics and controls. 
The MLD values were significantly lower in asthmatics compared with controls in sub- 
jects aged between 60 and 69 years and over age 70. RAgso values were significantly 
higher in asthmatics compared with controls in subjects aged between 50 and 59 years, 
between 60 and 69, and over 70. %FEVI and FEV, /FVC were significantly decreased 
in elderly asthmatic patients over 70 years of age compared with the values in those 
under 49. Percent residual volume (%RV) was significantly larger in patients over 70 
years of age than in those between 50 and 59, and under 49 years. RAW was signifi- 
cantly larger in patients with steroid-dependent intractable asthma (SDIA) between 50 
and 59 years of age, and between 60 and 69 compared with RA 950 in those without 
SDIA. However, RAW did not differ significantly between SDIA and non-SDIA in pa- 
tients over age 70. The results suggested that in %LAA of the lungs on HRCT was 
significantly increased in the elderly subjects with and without asthma, and it was sig- 
nificantly higher in the elderly asthmatics than the elderly controls. 
Keywords aging, high -resolution computed tomography, low attenuation area, mean 
lung density, pulmonary function 
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Introduction 
influence of aging on HRCT lung densitometry 
in patients with asthma and control subjects. 
Asthma is characterized by airway inflammation, 
and an increase in airway smooth muscle' ' I ,  
mucous gland hypertrophy2', and reorganization 
of the extracellular matrix3' have been observed 
in the inflammatory process. Furthermore, airway 
reconstruction, such as bronchial wall thickening, 
bronchiectasis , emphysematous changes, and 
mosaic patterns of lung attenuation has been 
demonstrated by high-resolution computed tomo- 
graphy (HRCT) in patients with asthma" ". 
Asthmatics with abnormal HRCT findings have 
been shown to have poorer lung function and 
less hyperresponsive bronchi than those with 
normal HRCT findings6'. 
In contrast, previous studies have shown that 
low attenuation areas (LAA) on CT scans in 
vivo represent macroscopic and/or microscopic 
emphysematous changes in the lungs of patients 
with chronic obstructive pulmonary disease 
(COPD) ' 1 5 ' .  For the analysis of CT images, a 
quantitative method using digital data as well as 
a visual assessment of the scan is currently 
available7 "'. Some studies have investigated the 
use of CT lung densitometry in nonsmoking 
asthmatic patients'"", and our previous study 
suggested that mean lung density (MLD) and 
relative area of the lungs showing attenuation 
values less than -950 HU (RAU,,,) are signifi- 
cantly correlated with pulmonary function, pa- 
tient age, and disease severity in nonsmoking 
asthmatic patientsz0'. We also reported that de- 
creased CT lung density during asthma exacer- 
bation is at least partially reversible, and changes 
of MLD and RAW are related to the change in 
FEV I and residual volume"'. However, to our 
knowledge, the characteristics of asthma in the 
elderly have not been determined using HRCT. 
The purpose of this study was to investigate the 
Subjects and Methods 
Subjects 
Eighty asthmatics (60 females and 20 males ; 
mean age 58 years, range 19-80 years) and 
eighty healthy controls (55 females and 23 males ; 
mean age 59 years, range 24-83 years) were 
recruited from Misasa Medical Center. Asthma 
was diagnosed according to the definition pro- 
posed by the American Thoracic Society"'. All 
patients with asthma showed episodic symptoms 
of wheezing and coughing, and experienced 
symptomatic relief and reversible airway re- 
sponse with an accompanying increase in forced 
expiratory volume in one second (FEV, ) ex- 
ceeding 15% upon treatment with ,? -adrenergic 
agonists . Asthmatics were stable with no 
changes in asthma symptoms and medication for 
at least 1 month, except for the use of short- 
acting inhaled ,? ?-agonists. None of the sub- 
jects had a history of upper respiratory tract in- 
fection within the month prior to entry. Twenty- 
four of 80 patients had steroid-dependent intrac- 
table asthma (SDIA) and had been treated with 
glucocorticoids for more than 2 years. Control 
subjects were randomly selected from those vol- 
untarily visiting our hospital for an annual medi- 
cal examination. They had no historical or clini- 
cal evidence of allergic, respiratory or cardiovas- 
cular disease, had a normal chest radiograph, 
and normal values for spirometry. 
All subjects were lifelong nonsmokers. The 
subjects underwent high-resolution chest CT scan 
and pulmonary function tests on the same day. 
Asthmatics and controls were classified into four 
groups according to their age : 1 4 9  years ; 50- 
59 years ; 60-69 years ; 2 7 0  years. Each age 
group consisted of 20 asthmatics and 20 controls. 
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Atopy was evaluated by a combination of history 
of allergies, skin tests and the presence of se- 
rum IgE antibodies specific to the 12 common 
aeroallergens, including dust mites, pollens, 
molds, and animal danders. Serum- specific IgE 
was measured using the Pharmacia CAP " 
System (Pharmacia Diagnostics AB. Uppsala, 
Sweden). Atopic patients were defined as  those 
who had a positive skin test and/or the pres- 
ence of allergen - specific IgE. 
Informed consent was obtained from all sub- 
jects. The study protocol was approved by the 
ethics committee of our institution. 
Pulmonary function tests 
Pulmonary function tests were performed with 
a Chestac 33 (Chest Co. ,Tokyo, Japan). Forced 
vital capacity (FVC) , FEV I , FEV /FVC. resid- 
ual volume (RV) using the helium dilution 
method and carbon monoxide diffusing capacity 
(DLco) using the single breath method were 
measured. The  FVC, FEVI and RV measure- 
ments were expressed a s  a percentage of their 
predicted values (%FVC, %FEVI and %RV, re- 
spectively) according to the prediction equations 
of the Japanese Society of Chest Diseases'". 
DLco was also expressed a s  a percentage of the 
predicted values following the method of 
Nishida (%DLco) . The  ratio of FEVl to FVC 
(FEVI/FVC) was expressed as  a percentage. 
Computed tomography 
Each patient underwent noncontrast high- 
resolution computed tomography (HRCT) using 
a TOSHIBA Aquilion (TOSHIBA, Tokyo, Japan) 
scanner with 2 -mm collimation, a scanning time 
of 1 . 0  seconds, a voltage of 120 kVp, and a 
current of 200 rnA. All HRCTs were performed 
in supine patients following maximal inspiration. 
The images were reconstructed on a 32-cm field 
of view (FOV) using a standard algorithm (FC 
metry in the elderly 28 
1 0 ) .  Three HRCT scans were performed for de- 
termination of MLD and LAA : an upper section 
was obtained at the top of the aortic arch, a 
middle section was taken at the origin of the 
lower lobe bronchus, and a lower section was 
taken 3 cm above the top of the diaphragm, as  
described by Miniati et al. '". T h e  cut-off level 
between the normal lung density area and LAA 
was defined as  -950 HU, and RAsr,(, was calcu- 
lated using a method previously reported" " . 
I h e  MLD was calculated from the total cross- 
sectional area of the six lung hemislices ob- 
tained at the three anatomical levels. Similarly, 
the lung area occupied by voxels with attenua- 
tion values lower than -930 HU (ALISl,), obtained 
by summing the values of A',?" in each of the six 
hemislices, was expressed a s  a percentage of 
the total lung cross-sectional area (KAc , ; a )  . 
HRCT lung densitometry was performed for 
each subject by means of a dedicated software 
program from TOSHIBA. 
Statistical Analysis 
All statistical analyses were carried out using 
Stat View software (SAS Institute Inc., NC, USA). 
Results were expressed a s  means *SD. Serum 
IgE levels were given a s  the geometric mean 
and range. Analysis of variance (ANOVA) with 
Bonferroni/Dunn correction was used to com- 
pare groups. A p value <0.05 was regarded as  
statistically significant. 
Results 
Asthmatic patient characteristics 
Asthmatic patient characteristics, pulmonary 
function tests ,  and current medications are 
shown in Table 1 .  Among the four groups. 
there were no statistically significant differences 
in disease duration, sex distribution, number of 
patients with SDLA or medications used. The  
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mean serum IgE level in patients under age 49 
was the highest of the four groups. The preva- 
lence of atopy was significantly higher in those 
under age 49 than in those aged between 60 
and 69 (p< 0.05) . The %FVC was significantly 
lower in those over age 70 than in either those 
under age 49 (p<0.01) or aged between 50 
and 59 (p<O. 05) , and was also significantly 
lower in those aged between 60 and 69 than in 
those under age 49 (p<O. 05). The mean val- 
ues of %FEVI (p<O. 05) and FEVI /FVC (p 
<0.01) were significant lower in those over 70 
years of age than in those under age 49. %RV 
was significantly higher in those over 70 years 
of age than in either those under age 49 (p< 
0.01) or aged between 50 and 59 (p<O. 05). 
Tahle 1. Patrent e h a r a c t e r ~ s t ~ e s  a n d  me&eat~on use among groups classfied by age 
Asthma 
549 years 50 59 yearn 60 69years 705 years 
ln=20) in=20) (n=20) (n=20J 
Maleifemale, n 7113 2118 5115 6114 
Agc alonsct, years(SD) 22 7(14 8) 39 31128)'. 50 2(12 3)" 583114 1)"" 
Dlaease duration years iSD) 12 0 (7 9) 17 2 (13 7) 14 6 I12 0) 16 4 (13 3) 
Patmenls v ~ r h  SDlA n 5 7 6 6 
Serum IgE. Iblml (range)* 809 I45 5195) 182 (10-1124)" 250 (33 1646)" 101 (11-2918)' 
A t o ~ ~ l n o n a f ~ p y ,  n 1614 1218 1113' Loll0 
FVC.%pred (SD) 105 6 I15 6) 
FEV,.%pnd (SD) Sa 3 (12 4) 
FEV,IFVC. X (SD) 770l110)  
RV.%pred ISD) 111 31229) 
D~cu.%pred (SD) 104 9113 0) 
Med,cat,on, n 
Inhaled sterol& 18 
TheophyU~ne 12 
LTRA 12 
Values are presented as mean t SD m parentheses 
geometric mean and ranre 1" parentheaea 
SDM = s tero~d dependent tntraelable asthma 
FVC -forced viral capanty Kpmd =percentage of the predzted value 
FEV, = farced erpvntory volume m one m o d  RV = reardual volume 
DLCO = Lffiarng eapaoty of the lung lar carbon munoxade 
LTRA = leukotmene Raeptor anUgonnD 
*. pCO 05 p<O 01 m u 8  aathmatm underage 49 
' " pc0 05 p<O 01 remw sathmatm between age SO and 59 
Patients over 70 showed the lowest %DLco val- 
ues of all four age groups. All asthmatic pa- 
tients were treated with inhaled ,? 2 agonists. 
The mean dose of inhaled BDP (beclomethasone 
dipropionate) was 530 ,I g/day for those under 
age 49, 580 ,U g/day for those aged between 
50 and 59,  470 ,U g/day for those aged 
between 60 and 69, and 570 , ~ g / d a y  for those 
over age 70. In control subjects, %FVC was 
110.0+17.8%, %FEVl was 112.8+16.5%, 
and %FEVI /FVC was 80.5+6.5%. 
Correlation between age and HRCT lung 
densitometry in asthmatics and controls 
Figures 1 and 2 show the correlations be- 
tween subjects' age and HRCT measurements. 
Significant statistical negative correlations were 
observed in both asthmatics and controls be- 
tween age and MLD (Figure 1) .  The RAgSo had 
significant positive correlations with subjects' age 
in both asthmatics and controls (Figure 2 ) .  
Age (years) 
B. 
Age (years) 
Figure 1. 
Figure 1. Correlation between age and MLD in 
controls (A) and asthmatics (B). 
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A. Table 2 rompar ln~n hrhvprn contnk. and dfrhmalio in HRrT 
lung d?nrltonlrtry class6ed by a l e  
MLD (HU) RA,.,,(%l 
control asthma P control asthma p 
549 yearn 868 (20) 876 (20) KS 3 1(? 4) G 1 (5 6 )  NS 
50 59 g ~ a n  873 (16) 882 (281 NS 3 5 (2 6) 8 7 (7 9) <I1 115 
60-69years -871 (21) 895118) <OW1 4 l ( 3 8 )  147(11 8) '0001 
70iyearn 885(20) -30J(191 c o o l  d6(G 1) 196(Ll  11 <OW1 
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Values are pwsented aa mean and SD 10 pawnrhesla 
MLD = mean lung denmty 
0  R%ew = ~ l a t ~ e  areaof the lung* ahawlng atf~nuatlon values l e ~  than 950 H U  
1 0 2 0 3 0 4 0 5 0 6 0 7 0 8 0 9 0  HI: = Hounsfield Units 
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B. 
50 
• • I RAgw in patients with SDlA 
Age bears) 
Figure 2. 
Figure 2. Correlation between age and RA9w in 
controls (A) and asthmatics (B). 
Comparison of HRCT lung densitometry be- 
tween age groups 
The  results of HRCT lung densitometry in 
each age group are shown in Table 2 .  The  
MLD values were significantly lower in asthmat- 
ics compared with controls in subjects aged be- 
RA,.,, was significantly larger in patients with 
SDIA aged between 50 and 59 (p<  0.001) , and 
between GO and 69 (p<O. 051, compared with 
the RA'li,l in those without SDIA from the same 
age group. However, RAgs1 did not differ signifi- 
cantly between SDIA and non-SDIA in patients 
over age 70 (Fig. 3 ) .  
549 yrs 50-59 yrs 60-69 yrs 705 yrs 
tween 60 and 69 and over age 70. R A 9 l I 1  values 
were significantly higher in asthmatics compared Figure 3. 
with controls in subjects aged between 50 and 
~i~~~~ 3. R A ~ ~ ~  in patients with steroid-depend- 
59, aged between 60 and 69, and over age 70. ent intractable asthma (SDIA) (.) and non- 
SDIA (Ojin four groups classified by age. 
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Discussion 
To clarify the characteristics of the elderly, 
HRCT lung densitometry (MLD and RAgso) and 
pulmonary function (%FEVI and %RV) were 
examined in healthy controls and stable asthmat- 
ics classified into four groups according to age 
(<49, 50-59, 60-69, 2 70 years). In terms of 
pulmonary function, measurements of airflow 
limitation (%FEVI , FEVI /FVC) and %DLco 
were significantly decreased, and %RV was sig- 
nificantly increased in stable asthmatics over 70 
years of age compared with the values in those 
under age 49. The results suggest that pulmo- 
nary function (%FVC, %FEVI, FEVI /FVC, 
and DLco) is clearly decreased in asthmatics 
over 70 years old. 
MLD tended to decrease significantly and RAgso 
showed a tendency to increase with aging in 
both asthmatics and controls. M 9 5 0  was signifi- 
cantly higher in asthmatics compared with con- 
trols in subjects between 50 and 59, between 60 
and 69, and over age 70. RA9S was also signifi- 
cantly larger in patients with SDIA aged be- 
tween 50 and 59, and between 60 and 69 years, 
compared with RAYS0 in those without SDIA from 
the same age groups ; however, a significant 
difference was not found in M 9 5 0  between SDIA 
and non-SDIA in elderly patients over 70 years 
old. The results suggest that RA9.w is mainly in- 
fluenced by aging in patients over 70. In contrast, 
RAysa is affected by severity of the disease as 
well as aging in patients aged between 50 and 
59, and between 69 and 69. The relationship 
between RAgsO and %FEVI or %RV was statisti- 
cally significant in asthmatics over 50 years of 
age, but not in those under 49. 
Some studies have demonstrated that the du- 
ration of asthma is associated with airflow limita- 
tion and hyperinflationzwn' . We previously 
demonstrated that HRCT lung densitometry 
was correlated with patient age and severity of 
asthmaz0', and that RAgN in asthmatics with a 
smoking history indicates the presence of em- 
physema, whereas in nonsmoking asthmatics it 
reflects hyperinflation and nonemphysematous 
expiratory airflow limitation rather than emphy- 
sematous lesionslg'. In the present study, we 
found significantly decreased %FEVI and signifi- 
cantly increased %RV and RAsw in patients over 
70 years old compared with the values in those 
under 49. The results show that airflow limita- 
tion and hyperinflation as expressed by RAm 
were mainly associated with aging in patients 
aged over 70, and partially associated with dis- 
ease severity in those between the ages of 50 and 
69, but not with disease duration. However, 
Quadrelli et a]. demonstrated that airflow im- 
pairment is related not to age itself, but to the du- 
ration of asthmaz5'. The discrepancy between 
their study and the current study may be ex- 
plained by disease severity. Twenty-four pa- 
tients with SDIA (30%) were included in our 
study, whereas none were included in their study. 
The subjects in our study therefore had a 
higher disease severity than those in their study. 
We used -950HU as the cut-off level between 
normal lung density area and LAA. Previous stud- 
ies have used variable levels ranging from -900 
to -960 HU7 l5.%,2Y] 
. This discrepancy may be at- 
tributed to variations between the CT scanning 
techniques (equipment and reconstruction of im- 
ages) as well as CT images (conventional vs. high 
resolution) . In our study, using HRCT of 15 
healthy controls, we found the mean MLD mi- 
nus l SD to be -949 HU. 
Gevenois et al. reported that both MLD and 
RAW are influenced by TLC, and to a lesser ex- 
tent by age in healthy subjects"'. This was fur- 
ther supported by a longitudinal study from 
Soejima et a l .  who studied images of 
HRCT lung densiton ~ e t r y  in the elderly 32 
nonsmoking subjects over a study period of 5 
years3". The present study revealed that an in- 
creased RAgso may be largely influenced by age 
in patients over 70 years old. In contrast, the 
present results also show that R.4950 is affected 
by both aging and disease severity in patients 
between the ages of 50 and 69. 
We conclude that decreased HRCT lung den- 
sity, airflow limitation and hyperinflation are 
closely related to age in nonsmoking asthmatics 
over age 70. The decreased HRCT lung density 
may represent chronic overinflation in elderly 
patients with asthma. These results suggest that 
HRCT scanning may be a useful tool to deter- 
mine functional characteristics, especially in eld- 
erly patients with asthma. 
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高分解能CTlung densitometryにおける高齢者  
の臨床的特徴  
光延文裕，保崎泰弘，芦田耕三，岩垣尚史，  
永田拓也，藤井 誠，高田真吾，横井 正1），  
浜田全紀1），谷崎勝朗  
岡山大学医学部・歯学部附属病院三朝医療センター  
内科，1）リハビリテーション科  
高齢者の病態的特徴を明らかにするために，健  
常者80例および非喫煙喘息患者80例を対象として，  
平均肺CT値（MLD）ならびに高分解能CT（HRCT）  
による－950HU以下の肺low attenuation area  
（RA95。）を評価し，年齢及び肺機能との関連を検  
討した。1．健常者，哨息患者いずれにおいても  
年齢とともにMI月は有意に減少し，RA95。は有意  
に増加した。MI♪は，60－69歳と70歳以上の年  
齢層において，健常者に比して喘息患者で有意に   
低値を示した。RA95。は，50－59歳・60－69歳・70  
歳以上の年齢層において，健常者に比して哨息患  
者で有意に高値を示した。2．喘息患者において，  
1秒量（％FEVl）および1秒率（FEVl／FVC）は，  
49歳以下の年齢層に比して70歳以上の年齢層で有  
意に低値を示した。一方，残気量（％RV）は，50－  
59歳ならびに49歳以下の年齢層に比して70歳以上  
の年齢層で有意に高値を示した。3．50－59歳お  
よび60－69歳の年齢層では，RA95。は，ステロイ  
ド依存性重症難治性喘息（SDIA）患者において非  
SDIA患者に比して有意に高値を示した。しかし，  
70歳以上の年齢層では両者に有意の差は認められ  
なかった。これらの結果より，HRCT上の肺low  
attenuationareaは高齢者において有意に増加す  
ること，さらに嘱息患者の方が健常者に比してよ  
り高値を示すことが示唆された。  
索引用語：加齢，高分解能CT，低吸収域，平均C  
T値，肺機能   
